Virus cocktail takes on Antibiotic-Resistant foot infections

NCT ID NCT05948592

Completed Disease control Sponsor: Technophage, SA Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tested a topical treatment called TP-102, a mix of five viruses that target bacteria, in 76 people with diabetic foot infections. The goal was to see if it is safe and helps heal wounds. The treatment is applied directly to the ulcer every other day.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TP-102 (a cocktail of 5 viruses that attack bacteria)
What this could lead to: If it works, this could offer a new way to treat diabetic foot infections that are resistant to antibiotics.
What could go wrong: This is a small, early-phase trial focused on safety and wound healing. The treatment may not prove effective, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT INFECTION

Contacts and locations

Locations

Aman Hospital & Research Centre

Vadodara, 390021, India
Clemente Clinical Research

Los Angeles, California, 90033, United States
Crescent Hospital & Heart Centre

Nagpur, 440012, India
GSVM Medical College

Kanpur, India
Jupiter Hospital & Research Center

Vadodara, 390012, India
MV Hospital for Diabetes Pvt. Ltd

Chennai, 600013, India
Parikh Multispeciality Healthcare Pvt. Ltd

Vadodara, 390020, India
Shree Siddhi Vinayak Hospital

Nashik, 422002, India
Tranquil Clinical Research

Webster, Texas, 77598, United States
Yalamanchi Hospitals & Research Centers Pvt. Ltd

Vijayawada, 520002, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.